A Phase 2 trial (NCT01311518) was designed to test RGN-352 in ~75 heart attack patients, but was placed on FDA clinical hold in 2011 due to manufacturing (GMP) compliance issues at the contract site not safety concerns with the drug itself
Important Administration Tips Begin on a small dose and observe reaction
Hair follicles undergo continuous cycles of growth (anagen), regression (catagen), and rest (telogen) phases, with the duration and quality of anagen determining overall hair production and appearance
Weekly administration may lead to patients being noncompliant, as they have to frequently remember to take their medication
Every vitamin injections plan begins with a complimentary consultation, so your provider can understand your goals and design a personalized approach built around safety and natural-looking results
How Should You Interpret Oral Peptide Claims